Ranolazine for the Symptomatic Treatment of Patients With Chronic Angina Pectoris in Greece: A Cost-Utility Study

BMC Health Services Research - United Kingdom
doi 10.1186/s12913-015-1228-y
Full Text
Abstract

Available in full text

Categories
Health Policy
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Cost-Effectiveness of Ranolazine for the Treatment of Angina Pectoris in Russia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

The Treatment of Angina Pectoris

New England Journal of Medicine
Medicine
1959English

Treatment of Angina Pectoris

Japanese Circulation Journal
1956English

Surgical Treatment of Angina Pectoris

JAMA - Journal of the American Medical Association
Medicine
1924English

The Operative Treatment of Angina Pectoris

BMJ
1921English

Treatment Optimization in Patients With Stable Angina Pectoris: Focus on Verapamil Sr

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2011English

Nicotinic Acid in the Treatment of Angina Pectoris

Heart
Cardiovascular MedicineCardiology
1944English

The Cost-Effectiveness of Four Chinese Patent Medicine in the Treatment of Angina Pectoris in China

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Effect of K-351 (Nipradilol) on Exercise Tolerance in Patients With Chronic Stable Angina Pectoris.

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
1986English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy